In Post menopausal osteoporosis Osteoporosis is a common condition that weakens bones, making them fragile and more likely to break. It often occurs in women after menopause. This condition can be treated with bone-strengthening medicines. Calcimax ISO Capsule contains supplements that strengthen bones by increasing calcium absorption. This maintains bone density and reduces your risk of bone loss in women after menopause.
It is unsafe to consume alcohol with Calcimax ISO Capsule.
Information regarding the use of Calcimax ISO Capsule during pregnancy is not available. Please consult your doctor.
Information regarding the use of Calcimax ISO Capsule during breastfeeding is not available. Please consult your doctor.
It is not known whether Calcimax ISO Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
There is limited information available on the use of Calcimax ISO Capsule in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Calcimax ISO Capsule in patients with liver disease. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More